每一个经历校招的大学生都纷纷表示:太难了! #校招后我不会轻视任何一个岗位#话题 更是顺势 冲上了热搜。 其实,所谓的“校招后遗症”,一方面源自我们对“自我定位”的迷茫,另一方面也反映出我们对“岗位价值”的重新认知!
创新药支付难,一直是我国生物医药发展的“老大难”问题。但从2024年年底开始,政策形势陡然发生了变化,利好信号频传,支持创新药发展的消息、重磅文件被密集放出,几乎全部指向解决创新药的定价与支付难题。
DeltaHealth Hospital·Shanghai has been granted an operating license in Shanghai, making it the city's first wholly ...
China's Consumer Price Index (CPI) decreased 0.7 percent year-on-year while the Producer Price Index (PPI) declined by 2.2 ...
Last November, Chinese automaker SAIC-GM-Wuling (SGMW) rolled a compact electric vehicle model off the assembly line at its subsidiary in Indonesia. The sleek four-seater, the subsidiary's 160,000th v ...